Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
Myelin in cartilaginous fish.
Dimethyl fumarate protection against collagen II degradation.
Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination.
Chronic mild stress eliminates the neuroprotective effect of Copaxone after CNS injury.
The effects of prolonged wear of textured shoe insoles on gait, foot sensation and proprioception in people with multiple sclerosis: study protocol for a randomised controlled trial.
Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.
Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline.
Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.
Alpha/beta interferon is a neuronal growth factor.
Cost-effectiveness of glatiramer acetate and interferon beta-1a for relapsing-remitting multiple sclerosis, based on the CombiRx study.
Some recent advances in multiple sclerosis.
FGF-1 Triggers Pannexin-1 Hemichannel Opening in Spinal Astrocytes of Rodents and Promotes Inflammatory Responses in Acute Spinal Cord Slices.
Atypical facial pain in multiple sclerosis caused by spinal cord seizures: a case report and review of the literature.
Detailed results from Biogen Idec and AbbVie's pivotal Phase 3 DECIDE study further define the efficacy and safety profile of ZINBRYTA™ (daclizumab high-yield process)
Clobetasol promotes remyelination in a mouse model of neuromyelitis optica.
Social Support in Relation to Fatigue Symptoms Among Patients with Multiple Sclerosis.
Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Sema4A inhibits the therapeutic effect of IFN-β in EAE.
Neuro-Immune Interactions at Barrier Surfaces.
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
Novantrone
Salvianolic acid B protects the myelin sheath around injured spinal cord axons.
Pages
« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »